Axovant Sciences Ltd (NYSE:AXON)‘s stock had its “buy” rating reissued by research analysts at Oppenheimer Holdings Inc. in a research report issued to clients and investors on Wednesday. A number of other research firms also recently weighed in on AXON. Cowen and Company initiated coverage on Axovant Sciences in a report on Tuesday, February 14th. […]
